Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Initial Patient Target Achieved for Glivec within 3 Months
April 1, 2002
- METI to Support 386 Technological Development Projects
April 1, 2002
- New Standard Prices for Medical Materials Announced
April 1, 2002
- Takeda's New Invoice Prices More Closely Reflect Price Reductions Than Before
April 1, 2002
- REGULATORY NEWS IN BRIEF
April 1, 2002
- JIRA Is Enthusiastic about Forming New Medical Device Approval System
April 1, 2002
- Sankyo Drastically Reduces "Slide Rate"
April 1, 2002
- We Must Do Structural Reform: Mr Takemi, Diet Member
April 1, 2002
- Hitachi Medical: Digital Ultrasonic Diagnostic Device, EUB-6500
April 1, 2002
- Fukujin to Up Sales to \1 Trillion in 5 Years
April 1, 2002
- Profit-making Corps. Not to Join Hospital Operation: Dr Itouji of JMA
April 1, 2002
- MEDICAL DEVICE NEWS IN BRIEF
April 1, 2002
- Newly Merged Wholesaler Koyo to Get No. 3 Share in Shikoku
April 1, 2002
- 26th JMC General Assembly to Invite Citizens to Participate
April 1, 2002
- Yamanouchi Ties Up with Metabolex for Discovering Diabetes Drugs
April 1, 2002
- Nikken Chemicals to Focus on Drugs
April 1, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 1, 2002
- Sawai Sees 23.48% Reduction in NHI Prices
April 1, 2002
- Only 10-20% of Patients with Osteoporosis Receiving Treatment: WLJ Seminar
April 1, 2002
- Taiyo to Start Strategy to Promote Use of Generics
April 1, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…